Brind.

Relmada Therapeutics Inc. must secure GMP manufacturing capacity for its IND filing.

1 report, 1 independent Updated Aug 8
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Relmada Therapeutics Inc. must secure GMP manufacturing capacity for its IND filing.

Who's involved

What this event is mainly about
GMP

Keep exploring

The entities involved

  • GMP

    company in the Czech Republic

    Nothing else this week.

Coverage

Newest first; wire copies grouped